Liquidation09557364Private limited companyManchester

PERTINAX PHARMA LIMITED

Significant control: R&H Trust Co (Jersey) Ltd Perivoli Innovations (25–50%)

In liquidationThe company is being wound up. A liquidator deals with its affairs, assets and creditors' claims. Status as shown on the Companies House register at 31 August 2026; it may have changed since. Check the live record.

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Pertinax Pharma Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Pertinax Pharma Limited sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy

Summary

Generated from filed data · no estimates

PERTINAX PHARMA LIMITED is a liquidation private limited company (company number 09557364) incorporated on 23 April 2015, registered in Manchester. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (total exemption full) but not yet parsed into this record.

There are 138 companies in research and experimental development on biotechnology in Manchester with filed accounts; the median reports net assets of £436 and is 7 years old.

Ownership and control

1 active · 1 other

R&H Trust Co (Jersey) Ltd Perivoli Innovations
corporate entity · since 23 January 2018
- owns 25–50% of shares
25–50%
University Of Bristol
corporate entity · since 6 April 2016 · ceased 23 January 2018
- owns 25–50% of shares
25–50%

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

Key dates

Incorporated: 23 April 201511 yrs ago
First accounts due: 23 January 20173562 days overdue
Confirmation statement due: 7 May 2027in 194 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 72110: Research and experimental development on biotechnology
Accounts type: Total Exemption Full

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

Filing and accounts signals

Facts from the register · no rating

Incorporated five or more years agoIncorporated 23 April 2015
Register status is not ActiveLiquidation

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

Timeline

Newest first

07 May 2027Confirmation statement duein 194 days
23 Jan 2017First accounts due3562 days overdue
23 Apr 2015Incorporated

Similar companies in Manchester

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 23 April 2015 · in Apr 2015.

Reminders for PERTINAX PHARMA LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.